Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kymera Therapeutics

Explore full profile

A biotechnology company pioneering a transformative new approach to treating previously untreatable diseases

Cambridge, United StatesFounded 2016Biotech & Life Sciences
Valuation $7.92B Market cap · Aug/2026
Revenue $85M Latest reported FY

At a glance

Status
Listed
Founded
2016
Headquarters
Cambridge, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later9 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 306 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Kymera Therapeutics employees who went on to found companies, sorted by Dealroom signal score.

Fortitude BiomedicinesEst. 2025
Jesse ChenUnited States
Signal score91
PAQ TherapeuticsEst. 2020
NJNan JiUnited States
Signal score81
Orbital TherapeuticsEst. 2022
John MaraganoreUnited States
Signal score62
Parthenon TherapeuticsEst. 2019
LALaurent AudolyUnited States
Signal score61
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States98.5%
🇨🇦 Canada1%
🇲🇾 Malaysia0.5%
3 countries shown
Web traffic by country
22K monthly visits
across markets
🇺🇸 United States73.6%
🇬🇧 United Kingdom11.4%
🇮🇳 India7.7%
🇯🇵 Japan4.1%
🇫🇷 France2.3%
Top 5 markets shown

Patents

Estimated portfolio value
$28M

98 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kymera Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kymera Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles